Search Within

Shanu Modi

  1. "Sloan Kettering Institute Faculty"
Formats
  1. Journal Article (21)
  2. Meeting Abstract (20)
  3. Review (1)
Groups
  1. Breast Medicine Service (42)
  2. Department of Medicine (42)
  3. GSK Faculty (42)
  4. Sloan Kettering Institute Faculty (42)
  5. Solid Tumor Oncology Division (42)
  6. Molecular Pharmacology and Chemistry Program Faculty (41)

More Groups

People
  1. Clifford Hudis (21)
  2. Gabriela Chiosis (18)
  3. Neal Rosen (16)
  4. Adriana Dionigi Corben (12)
  5. Tony Taldone (12)
  6. Komal Jhaveri (11)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2021 (2)
  4. 2020 (3)
  5. 2019 (6)
  6. 2018 (1)

More Years

Publications
  1. Cancer Research (9)
  2. Journal of Clinical Oncology (7)
  3. Clinical Cancer Research (4)
  4. Breast Cancer Research and Treatment (2)
  5. Clinical Breast Cancer (2)
  6. Nature Communications (2)

More Publications

Publishers
  1. American Association for Cancer Research (14)
  2. American Society of Clinical Oncology (8)
  3. Nature Publishing Group (4)
  4. Cell Press (2)
  5. Elsevier Inc. (2)
  6. Springer (2)

More Publishers

Results (42)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phosphorylation-driven epichaperome assembly is a regulator of cellular adaptability and proliferation
    Journal Article

    Roychowdhury, T.; McNutt, S. W.; Pasala, C.; Nguyen, H. T.; Thornton, D. T.; Sharma, S.; Botticelli, L.; Digwal, C. S.; Joshi, S.; Yang, N.; more...
    Nature Communications (2024)

    Fulltext@MSK | Save
  • Systems-level analyses of protein-protein interaction network dysfunctions via epichaperomics identify cancer-specific mechanisms of stress adaptation
    Journal Article

    Rodina, A.; Xu, C.; Digwal, C. S.; Joshi, S.; Patel, Y.; Santhaseela, A. R.; Bay, S.; Merugu, S.; Alam, A.; Yan, P.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
    Journal Article

    Adusumilli, P. S.; Zauderer, M. G.; RivieĢ€re, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • A phase I study of alpelisib in combination with trastuzumab and LJM716 in patients with PIK3CA-mutated HER2-positive metastatic breast cancer
    Journal Article

    Jhaveri, K.; Drago, J. Z.; Shah, P. D.; Wang, R.; Pareja, F.; Ratzon, F.; Iasonos, A.; Patil, S.; Rosen, N.; Fornier, M. N.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Measuring tumor epichaperome expression using [(124)I] PU-H71 positron emission tomography as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2-negative metastatic breast cancer
    Journal Article

    Jhaveri, K. L.; dos Anjos, C. H.; Taldone, T.; Wang, R.; Comen, E.; Fornier, M.; Bromberg, J. F.; Ma, W.; Patil, S.; Rodina, A.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • First-in-human trial of epichaperome-targeted PET in patients with cancer
    Journal Article

    Dunphy, M. P. S.; Pressl, C.; Pillarsetty, N.; Grkovski, M.; Modi, S.; Jhaveri, K.; Norton, L.; Beattie, B. J.; Zanzonico, P. B.; Zatorska, D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Molecular stressors engender protein connectivity dysfunction through aberrant N-glycosylation of a chaperone
    Journal Article

    Yan, P.; Patel, H. J.; Sharma, S.; Corben, A.; Wang, T.; Panchal, P.; Yang, C.; Sun, W.; Araujo, T. L.; Rodina, A.; more...
    Cell Reports (2020)

    Fulltext@MSK | Save
  • Paradigms for precision medicine in epichaperome cancer therapy
    Journal Article

    Pillarsetty, N.; Jhaveri, K.; Taldone, T.; Caldas-Lopes, E.; Punzalan, B.; Joshi, S.; Bolaender, A.; Uddin, M. M.; Rodina, A.; Yan, P.; more...
    Cancer Cell (2019)

    Fulltext@MSK | Save
  • Regional delivery of mesothelin-targeted CAR T cells for pleural cancers: Safety and preliminary efficacy in combination with anti-PD-1 agent
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R.; Zhu, A.; Ngai, D.; McGee, E.; Chintala, N.; Messinger, J.; Cheema, W.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Ngai, D. A.; McGee, E.; Chintala, N. K.; Messinger, J. C.; Vincent, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save